Common Lifestyle Program: Clinical Trials

1 trial of Common Lifestyle Program, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Common Lifestyle Program: new trials by email Literature Review of Common Lifestyle Program trials Research Report on Common Lifestyle Program

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial
Dapagliflozin, Metformin, Common Lifestyle Program - Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain
Phase 4Not yet recruitingSultan Qaboos University1102026-09-012026-06-10

Conditions studied

Psychotic Disorders (1)

Sponsors

Sultan Qaboos University (1)

Countries

Oman (1)

Top investigators

Mohammed Al Alawi, MD, PhD (1)